Jenscare Scientific Co., Ltd. (09877.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 7.60

From 52W high−40.03%

Volume10000.00

Market capHKD 3.10B

P/E (TTM)—

P/S (TTM)18.9x

Div yield—

Key dataSep 18, 2026

Open

HKD 7.60

From 52W high

−40.03%

Volume

10000.00

Market cap

HKD 3.10B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−18.3x

P/E (TTM)

—

RSI (14)

46.8

MomentumView details →

1D Return

−4.20%

YTD Return

−19.27%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−18.3x

EV/Sales

16.1x

P/S (TTM)

18.9x

P/B (TTM)

3.5x

ProfitabilityView details →

Gross Margin

76.50%

Net Margin

−106.17%

EBITDA Margin

−88.30%

ROE (TTM)

−19.82%

ROA (TTM)

−17.67%

Asset Turnover

0.16x

GrowthView details →

Revenue YoY

+1986.63%

EPS YoY

+14.10%

FCF YoY

+108.36%

Revenue CAGR 3Y

—

EPS CAGR 3Y

−48.84%

EBITDA YoY

−83.89%

MomentumView details →

1D Return

−4.20%

YTD Return

−19.27%

1Y Return

−16.45%

RSI (14)

46.8

vs 50D SMA

−2.33%

vs 200D SMA

−12.99%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

6.98x

Quick Ratio

6.44x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.13

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

146.79M

Net Income (TTM)

−233.57M

Op. CF (TTM)

−141.29M

Next earningsMar 31, 2027 →

Latest newsMore news →

Jenscare Scientific Co., Ltd. reported interim results for the six months ended June 30, 2026, with revenue of RMB 64.13 million, up 377.7% year-over-year, and a narrowed net loss of RMB 48.69 million compared to RMB 170 million in the prior-year period.20d ago

Jenscare Scientific's LuX-Valve Plus system completed the first patient implantations in the FDA-approved pivotal clinical trial in the United States.66d ago

Similar companies

祥生医疗688358.SH Ekso Bionics Holdings, Inc. Common StockCHRN 健麾信息605186.SH 安旭生物688075.SH 东方生物688298.SH 科美诊断688468.SH Find similar companies →

Latest newsMore news →

Jenscare Scientific Co., Ltd. reported interim results for the six months ended June 30, 2026, with revenue of RMB 64.13 million, up 377.7% year-over-year, and a narrowed net loss of RMB 48.69 million compared to RMB 170 million in the prior-year period.20d ago Jenscare Scientific's LuX-Valve Plus system completed the first patient implantations in the FDA-approved pivotal clinical trial in the United States.66d ago